Related references
Note: Only part of the references are listed.From airway inflammation to inflammatory bowel disease: Eotaxin-1, a key regulator of intestinal inflammation
Tomer Adar et al.
CLINICAL IMMUNOLOGY (2014)
Targeting Interleukins for the Treatment of Inflammatory Bowel Disease-What Lies Beyond Anti-TNF Therapy?
Mairi H. McLean et al.
INFLAMMATORY BOWEL DISEASES (2014)
Therapeutic drug monitoring in patients with inflammatory bowel disease
Andres J. Yarur et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2014)
Cytokines in inflammatory bowel disease
Markus F. Neurath
NATURE REVIEWS IMMUNOLOGY (2014)
CD14+CD33+ myeloid cell-CCL11-eosinophil signature in ulcerative colitis
Maria Lampinen et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2013)
Activated Eosinophils in Association with Enteric Nerves in Inflammatory Bowel Disease
Claire M. Smyth et al.
PLOS ONE (2013)
High-Throughput Multi-Analyte Luminex Profiling Implicates Eotaxin-1 in Ulcerative Colitis
Lori A. Coburn et al.
PLOS ONE (2013)
Inflammatory bowel disease pathogenesis: what is new?
Michael Scharl et al.
CURRENT OPINION IN GASTROENTEROLOGY (2012)
Immune markers and differential signaling networks in ulcerative colitis and Crohn's disease
George P. Christophi et al.
INFLAMMATORY BOWEL DISEASES (2012)
IBD-what role do Proteobacteria play?
Indrani Mukhopadhya et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2012)
L-arginine Supplementation Improves Responses to Injury and Inflammation in Dextran Sulfate Sodium Colitis
Lori A. Coburn et al.
PLOS ONE (2012)
Adalimumab in Crohn's Disease: Tips and Tricks After 5 Years of Clinical Experience
G. Fiorino et al.
CURRENT MEDICINAL CHEMISTRY (2011)
MEDICAL PROGRESS Ulcerative Colitis
Silvio Danese et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Inflammatory Bowel Disease
Arthur Kaser et al.
ANNUAL REVIEW OF IMMUNOLOGY, VOL 28 (2010)
Increased expression of chemokine receptor CCR3 and its ligands in ulcerative colitis: the role of colonic epithelial cells in in vitro studies
P. Manousou et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2010)
Therapeutic potency of IL2-caspase 3 targeted treatment in a murine experimental model of inflammatory bowel disease
S. Shteingart et al.
GUT (2009)
Intestinal Macrophage/Epithelial Cell-Derived CCL11/Eotaxin-1 Mediates Eosinophil Recruitment and Function in Pediatric Ulcerative Colitis
Richard Ahrens et al.
JOURNAL OF IMMUNOLOGY (2008)
A potent human anti-eotaxin1 antibody, CAT-213: Isolation by phage display and in vitro and in vivo efficacy
Sarah Main et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2006)
Immunopathogenesis of experimental ulcerative colitis is mediated by eosinophil peroxidase
E Forbes et al.
JOURNAL OF IMMUNOLOGY (2004)
IL-12 and IL-23: master regulators of innate and adaptive immunity
CL Langrish et al.
IMMUNOLOGICAL REVIEWS (2004)
Imbalance between interleukin-1 agonists and antagonists: relationship to severity of inflammatory bowel disease
O Ludwiczek et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2004)
Contribution of eotaxin-1 to eosinophil chemotactic activity of moderate and severe asthmatic sputum
G Dent et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2004)
The role of Th1/Th2 polarization in mucosal immunity
MF Neurath et al.
NATURE MEDICINE (2002)
Chemokines in pathology and medicine
M Baggiolini
JOURNAL OF INTERNAL MEDICINE (2001)
Distribution and activation of eosinophils in inflammatory bowel disease using an improved immunohistochemical technique
M Jeziorska et al.
JOURNAL OF PATHOLOGY (2001)
Increased serum levels of eotaxin in patients with inflammatory bowel disease
W Chen et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2001)
Share Paper
